ANI PHARMACEUTICALS INC 10-Q filing
Filed 2026-05-08 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001023024-26-000050
- Form type
- 10-Q
- CIK
- 0001023024
- Primary document
- https://www.sec.gov/Archives/edgar/data/1023024/000102302426000050/anip-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ANI PHARMACEUTICALS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $237.5M | - | - |
| Operating Income | $38.9M | - | - |
| Net Income | $29.5M | - | - |
| Eps Basic | 1.31 | - | - |
| Eps Diluted | 1.28 | - | - |
| Cash And Equivalents | $311.2M | - | - |
| Total Assets | $1.4B | - | - |
| Total Liabilities | $859.7M | - | - |
| Shareholders Equity | $562.3M | - | - |
| Operating Cash Flow | $58.4M | - | - |
| Capital Expenditures | $6.1M | - | - |